Stock Movers
Stock Movers

Sep 8, 2026 · 8 min

European stocks split between clinical risk and AI demand

Novartis Slumps, Rubis Gains, Computacenter Up

The episode connects sharp company-specific moves with broader questions about how technology and planning can reshape fast-growing cities.

3 key takeaways
  1. 1Novartis fell after a late-stage muscle-wasting disease trial failed, underscoring the market risk around pharmaceutical pipelines.
  2. 2Computacenter rose after upgrading profit guidance as strong AI-related spending strengthened its outlook.
  3. 3Rubis gained amid elevated energy prices while the episode examined AI and long-term planning in rapidly urbanizing cities.

Don't miss

The episode shifts from individual European stock moves to the larger question of whether AI and long-term planning can help cities absorb rapid population growth.

The brief

The episode opens with a question larger than the market: as urban populations grow rapidly, can cities make infrastructure smarter while meeting changing needs?

European stocks then take center stage. Novartis slumped after a failed phase-three muscle-wasting disease trial, while Computacenter gained after upgrading profit guidance.

Computacenter’s stronger outlook reflects robust AI-related spending, while French energy distributor Rubis benefited from elevated energy prices—different catalysts, same focus on expectations.

The closing discussion returns to urbanization, asking whether AI can accelerate smart-city systems and how Dubai is responding to population growth through long-term planning.

The episode’s central tension is whether innovation can keep pace with expansion, from pharmaceutical pipelines and corporate demand to the infrastructure of growing cities.

What was said on this episode

7 statements · 5 positive · 1 negative · 1 neutral

  1. Tiwa Adebayoon Novartis muscle-wasting disease treatmentNegative1:00

    Novartis’s muscle-wasting disease treatment failed its phase-three primary endpoint.

    “a treatment that they were developing for a muscle-wasting disease has failed to meet the primary endpoint in a phase three trial”

    Listen at 1:00

  2. Computacenter may exemplify Britain’s AI opportunity.

    “Computer Centre might be one of the shining examples of that in a UK context”

    Listen at 3:22

  3. Tiwa Adebayoon Rubis unit marginsPositive4:22

    Rubis has benefited from elevated energy prices supporting unit margins.

    “it has benefited from these elevated energy prices that we're seeing that supported unit margins”

    Listen at 4:22

  4. Rohit Krishnanon AI in smart citiesPositive5:43

    AI will compress processes and increase speed in smart-city systems.

    “AI will allow in the smart city space to compress a lot of things. The speed will change.”

    Listen at 5:43

  5. Estefanía Tapiason DubaiNeutral6:03

    Dubai learned from its sudden population increase.

    “Dubai has learned a lot from a sudden increase in population”

    Listen at 6:03

  6. Estefanía Tapiason Dubai’s population increase responsePositive6:09

    Dubai responded very well to its sudden population increase.

    “they reacted very well to it”

    Listen at 6:09

  7. Estefanía Tapiason Dubai urban planningPositive6:11

    Dubai has a long-term urban-planning vision.

    “they have a long-term urban planning vision”

    Listen at 6:11

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

European stocks split between clinical risk and AI demand | PodLume